MAKING THE CASE: CHEMOPREVENTIVE USE OF ASPIRIN FOR OVARIAN CANCER - INTEGRATING EPIDEMIOLOGICAL DATA TO EVALUATE POPULATION SUBGROUPS AND TUMOR EXPRESSION

The Geneva Foundation

Investigators